Carcinogenicity

Chemical hazard endpoint describing the potential to cause cancer, driving hazard classification, labeling, exposure controls, and restriction decisions.

Foresight tracks Carcinogenicity developments and surfaces the alerts most likely to matter before they turn into missed deadlines, recalls, or escalation work.

Not ready for a trial? Take the 3-minute readiness assessment

Current activity

Cooling

53% below the prior 8-week baseline

3-month trend

Latest alerts below

Last updated

23 May 2026, 08:56

View alerts

Latest Carcinogenicity developments

Source-backed regulatory and guidance signals tracked by Foresight, with the newest developments first.

New York Assembly Advances Baby Cosmetic Carcinogen Warning Bill A11360 To Rules Committee

On 20 May 2026, the New York State Assembly advanced Bill A11360, which would require ingredient and carcinogen-warning labels on infant cosmetic products, by reporting it from Codes to the Rules Committee. If enacted, baby cosmetic manufacturers and retailers selling into New York would need to redesign packaging, implement clear ingredient disclosure and cancer warnings, and be ready to comply within roughly six months of the law taking effect.

assembly.state.ny.usUnited StatesUnited States

Rhode Island Senate S2885: Consideration Scheduled For Asbestos Abatement And Radon Control Bill

Rhode Island’s Senate bill S2885, which would update asbestos abatement and radon control provisions, has been scheduled for Senate Health and Human Services Committee consideration on 21 May 2026. This keeps the proposal active, and building owners, employers, and remediation contractors in Rhode Island should track the hearing and prepare for possible changes to how asbestos and radon risks must be managed.

webserver.rilegislature.govUnited StatesUnited States

Netherlands RIVM Publishes Framework To Prioritise Substances For Health-Based Workplace Exposure Limits

In May 2026, RIVM published a framework and priority list of 49 groups of carcinogenic, mutagenic and reproduction-toxic substances for which the Dutch Health Council may develop health-based workplace exposure limits. This signals which chemicals are most likely to face early attention in future Dutch occupational exposure limit proposals, helping companies anticipate stricter controls, data needs and potential SZW limit-setting.

rivm.nlNetherlandsNetherlands

US VA Working Group Issues Toxic Exposure Report on Leukemias and Multiple Myeloma

The US Department of Veterans Affairs’ Military Environmental Exposure Sub-Council has issued its 2024 report to Congress summarising toxic exposure assessments and an ongoing scientific review of leukemias and multiple myeloma potentially linked to particulate matter from military airborne hazards and burn pits. While no new presumptions or benefits are created yet, the targeted completion of this review in October 2024 and ongoing selection of additional exposure conditions signal possible future changes in service-connection rules and veterans’ health entitlements that defence and healthcare stakeholders should monitor.

govinfo.govUnited StatesUnited States

Environmental Science & Technology Perspective Reviews PFAS Toxicity Evidence And Human Health Risks

A new peer-reviewed Perspective in Environmental Science & Technology consolidates epidemiological and toxicological evidence that PFAS exposure is linked to cancer, metabolic, immune, reproductive, developmental, and endocrine effects, directly challenging myths that PFAS health risks are uncertain or unproven. This strengthens the scientific basis regulators and companies rely on when setting PFAS limits and phase-out strategies, signalling continued momentum toward stricter, class-based PFAS controls across jurisdictions.

pubs.acs.orgGlobalGlobal

Louisiana SB 439 — Cancer Screening Requirements for Firefighters and Fire Service Employees

Louisiana has enrolled SB 439, a bill that would expand employer-funded cancer and precancer screening programmes for firefighters and fire service employees, with core obligations scheduled to take effect from August 2026 if it becomes law. Fire service employers in Louisiana should prepare screening programmes, provider arrangements, budgets and communications to meet the mandated schedules and to add oesophageal precancer screening from January 2027, while monitoring for final gubernatorial approval.

legis.la.govUnited StatesUnited States

OECD Opens First Commenting Round On Draft DRP For In Vitro Mammalian Cell Genotoxicity Methods (γH2AX, pH3)

The OECD has opened a public consultation from 15 May to 26 June 2026 on a draft Detailed Review Paper assessing in vitro mammalian cell genotoxicity assays based on the γH2AX and pH3 phosphorylated histone biomarkers. This review sits within the OECD Test Guidelines Programme and may shape future genotoxicity test guidelines, so companies relying on in vitro genotoxicity testing should track its outcomes and consider providing input via their National Coordinators.

oecd.orgGlobalGlobal

Cefic Amines Sector Group Challenges ECHA Response On Diethanolamine (DEA) CLP Classification

In April 2026 Cefic’s Amines Sector Group formally challenged ECHA’s response to the RAC opinion classifying diethanolamine (DEA) as Carc. 2 and Repr. 1B under the CLP Regulation, arguing that rodent-based choline depletion mechanisms are not relevant to humans. This challenge does not itself change obligations but could still influence the final harmonised classification and resulting labelling and risk management duties for DEA-containing products, so companies using DEA should monitor the 25th ATP outcome and plan for both stricter and more lenient classifications.

circabc.europa.euEuropean UnionEuropean Union

EUROTALC‑Funded Bayesian Bias Analysis Reassesses Talc–Ovarian Cancer Evidence

A EUROTALC-funded study in a medical research journal uses Bayesian quantitative bias analysis to show that reported links between genital talc use and ovarian cancer weaken to include no effect once recall bias is modelled. While it does not change existing IARC or ECHA classifications, this work provides a high-profile industry-backed challenge that regulators and litigants may cite in future reviews of talc cancer risk.

link.springer.comGlobalGlobalEuropean UnionEuropean Union

EUROTALC Requests RAC Reassessment of Talc Classification Under REACH

In April 2026, EUROTALC submitted a detailed letter to CARACAL urging the ECHA Risk Assessment Committee to reassess its proposed harmonised classification of talc, based on a newly published quantitative bias analysis showing recall bias likely explains observed associations between genital talc use and ovarian cancer. If regulators accept this analysis and reopen the weight-of-evidence review under Article 77(3)(c) REACH, the final EU classification outcome for talc—and therefore labelling, use conditions and potential restrictions across cosmetics and other applications—could change materially, so companies relying on talc should closely monitor the process.

link.springer.comEuropean UnionEuropean Union

Austria Supports RAC Opinion on Diethanolamine Classification Under 25th CLP ATP

Austria’s competent authority has formally backed the ECHA Committee for Risk Assessment proposal to classify diethanolamine (2,2'-iminodiethanol) as a carcinogen category 2 and reproductive toxicant category 1B, alongside existing acute and repeated-dose toxicity classifications, under the planned 25th adaptation to technical progress of the EU CLP Regulation. This non-binding but authoritative support makes it more likely that a stringent CMR classification for DEA will be retained in the final CLP ATP, so EU manufacturers and downstream users should prepare for tighter labelling, risk management and potential knock-on regulatory impacts once the amendment is adopted and in force.

echa.europa.euEuropean UnionEuropean UnionAustriaAustria

Slovakia Challenges Proposed CLP Annex VI Talc Classification (CA/19/2026)

On 30 April 2026 Slovakia’s chemicals authority formally challenged ECHA’s proposed Carc.1B and STOT RE1 harmonised classification for talc under the upcoming 25th ATP to the CLP Regulation. This intervention signals potential pressure to revisit the scientific and legal basis for talc and other PSLT particle classifications, which could delay or modify future EU labelling and risk management obligations.

circabc.europa.euEuropean UnionEuropean Union

California OEHHA Releases Draft Inhalation Unit Risk Factors for Ethylene Oxide and Acrolein and Schedules Public Workshops

California’s environmental health agency has released draft cancer inhalation unit risk factors for ethylene oxide and acrolein, opened public consultation through late June 2026, and scheduled June workshops in Sacramento and Los Angeles to present the assessments. These updated risk factors will feed into California’s Air Toxics Hot Spots programme, potentially tightening how facilities quantify and manage cancer risk from emissions of these two hazardous air pollutants.

oehha.ca.govUnited StatesUnited States

California OEHHA Opens Public Comment on Inhalation Unit Risk Factor for Ethylene Oxide

California’s environmental health agency has opened a new public consultation from 14 May to 29 June 2026 on its updated inhalation cancer risk factor for ethylene oxide used in state air-toxics assessments. This process signals continued regulatory focus on ethylene oxide emissions in California, and facilities using or emitting EtO should prepare for the possibility of tighter modeled cancer risk thresholds and follow-on control requirements once the value is finalised.

oehha.ca.govUnited StatesUnited States

California OEHHA Opens Consultation On Draft Cancer Inhalation Unit Risk Factors For Ethylene Oxide And Acrolein

In May 2026, California’s Office of Environmental Health Hazard Assessment opened a public consultation on draft cancer inhalation unit risk factors for ethylene oxide and acrolein, with comments due by late June 2026 and public workshops in Sacramento and Los Angeles. These revised toxicity values will underpin future air toxics risk assessments under the state’s Hot Spots programme, so facilities emitting these chemicals and manufacturers using them should assess potential impacts on permitting, control strategies, and long-term compliance plans.

oehha.ca.govUnited StatesUnited States

Italy: INAIL and CNA Sign Three-Year Protocol on Workplace Safety for Artisans and Small Businesses

Italy’s INAIL and CNA have signed a three-year cooperation protocol to develop guidance, monitoring campaigns and climate-resilient protective equipment addressing hardwood dust and respirable crystalline silica risks in artisans and small businesses. While it does not itself create new legal duties, the programme signals heightened attention to carcinogenic exposures under Italy’s workplace safety law and EU carcinogens rules, and may shape future guidance, incentives and enforcement priorities for small operators.

inail.itItalyItaly

ECHA Updates EU CLP Proposal for Acequinocyl With Chronic Aquatic M-Factor

In May 2026, ECHA updated Germany’s CLH proposal for the plant protection active substance acequinocyl under the EU CLP framework, with the proposed classification now including an M-factor of 1000 for both acute and chronic aquatic hazards alongside other severe hazard classes. If this harmonised classification is later adopted into CLP Annex VI, companies placing acequinocyl-based plant protection products on the EU market would need to reassess labelling, safety data sheets, and environmental risk controls to reflect the very high aquatic toxicity classification.

echa.europa.euEuropean UnionEuropean Union

New York Assembly Bill A11360 Proposes Warning Labels for Infant Cosmetic Products Containing Carcinogens

In May 2026 New York lawmakers introduced Assembly bill A11360, which would impose new ingredient and cancer-warning labelling requirements on infant cosmetic products sold in the state. If enacted, manufacturers and distributors of baby lotions, creams, oils and similar products would need to review formulations against state carcinogen definitions, update packaging, and manage the risk of civil penalties for non-compliant labelling.

assembly.state.ny.usUnited StatesUnited States

Defra Issues UK REACH Review Authorisations for ADCR Consortium Chromate Primers

Defra has issued four UK REACH review‑report authorisation decisions for members of the ADCR Consortium, allowing continued use and formulation of chromate‑based wash, bonding and other protective primers, as well as primer formulation, for aerospace and defence applications in Great Britain. The decisions extend access to critical hexavalent chromium primer systems under UK REACH while tightening exposure‑control and monitoring obligations at GB sites and setting time‑limited review periods for future reassessment.

gov.ukUnited KingdomUnited Kingdom

EU: ECHA Opens CLH Consultation On Harmonised Classification Of Cobalt Bis(2-Ethylhexanoate) (136-52-7)

In May 2026, ECHA opened an EU CLH consultation on a Dutch proposal to classify cobalt bis(2-ethylhexanoate) (CAS 136-52-7) as both Carc. 1B (H350) and Repr. 1B (H360FD) under the CLP Regulation, with comments due by 10 July 2026. If adopted, this harmonised CMR classification would require EU suppliers using this cobalt salt to align CLP labelling, safety data sheets, and mixture classification with the new Carc. 1B/Repr. 1B status and to reassess affected uses accordingly.

echa.europa.euEuropean UnionEuropean Union

Not a newsletter. Not a feed. Structured intelligence mapped to your business.

These are just a few of the most recent Carcinogenicity alerts. Foresight tracks every jurisdiction, every day — and surfaces only what affects your portfolio, with full citations and evidence.

Start free trial

Topic context

How to read Carcinogenicity regulatory activity

Definition

What is Carcinogenicity?

Chemical hazard endpoint describing the potential to cause cancer, driving hazard classification, labeling, exposure controls, and restriction decisions.

Industry relevance

Why it matters

Carcinogenicity developments can change product scope, supplier expectations, market access, reporting duties, and risk ownership. Foresight tracks the signals early so teams can respond before obligations become urgent.

Foresight tracking

How Foresight monitors it

Foresight monitors official sources, extracts structured regulatory intelligence, and maps alerts to a customer's products, substances, markets, and priorities so teams see the relevant signal with source evidence for review.

Frequently asked questions

Everything you need to know about Foresight's regulatory intelligence platform

Still have questions? Get in touch with our team

Join 3,500+ professionals staying ahead

Subscribe to Foresight Weekly for expert-picked regulatory developments across chemicals, sustainability, product safety, ESG, and HSE.

Free forever. Unsubscribe anytime.

Read by professionals at

Boeing
AstraZeneca
Siemens
PepsiCo
SpaceX